-
The intestinal microbiome is attributed as having a great impact on our health. However, the mechanisms behind this are still largely unknown. Scientists now have evidence that intestinal bacteria have a direct influence on the lipid metabolism of their host.
-
A recent scandal on donated body parts at a French university sparks a look back into the history of anatomy research in Europe and how social, economic, scientific, and legal dynamics shifted through the centuries.
-
The table classifies COVID-19 risk levels for different activities. The ranking is based on the assumption that, regardless of the activity, participants would adopt all possible protective equipment (first and foremost, masks).
-
A patient treated with infliximab for ulcerative colitis associated with COVID-19 reported pulmonary improvement within days. The case represents a first and could support the hypothesis that the drug is useful in the treatment of COVID-19.
-
A research project of the Ulm University Hospital (Germany) helps people with mental stress directly at work. The goal: Avoiding chronic symptoms, and reducing costs for social systems.
-
Researchers have identified parts of the SARS-Cov-2 viral envelope most frequently targeted by antibodies. Located on the "nails", or viral proteins, they represent a potential target for vaccine development.
-
Private or public, Spanish general medicine proved its worth during the pandemic. No town was neglected. Family physicians know their patients well and accompany them. These were key strengths for identifying contact persons or following up on patients even from a distance.
-
We speak with Annalisa Malara, a resuscitation/reanimatology physician, who discovered the first case of COVID-19 in Italy in February 2020.
-
esanum spoke with Prof. Dr. Matthias Weber, media spokesman of the German Society of Endocrinology (German acronym: DGE), about the state of endocrinology in the COVID-19 crisis.
-
Scientists studied the molecular evolution of tumors after exposure to genetically damaging chemicals. They discovered that the chemical-induced defects in individual DNA building blocks are not repaired immediately but are passed on over several rounds of cell division.
-
A new project called "DeLiver" is currently developing a transport system for liver transplants. This system ensures optimal monitoring of organ functions with a flexible temperature regulation, nutrition and oxygen supply of the organ.
-
The tissue hormone angiotensin II plays a role in the development of glaucoma. This finding could influence the diagnosis and therapy of glaucoma in the future.
-
Researchers used infrared (IR) microscopes based on quantum cascade lasers (QCLs) to classify tissue samples of colorectal cancer. Using AI, it was possible to differentiate tumor types with great accuracy within 30 minutes allowing for a prognosis of the disease and the therapy choice.
-
The Körber Prize for European Science 2020 will be awarded to Hungarian physician Botond Roska, who has revolutionized ophthalmology and the field of vision and retinal research. He has set himself the goal of restoring sight to the blind.
-
The University of Oxford announces that dexamethasone, a low-cost drug, reduces by up to one third the deaths of hospitalized COVID-19 patients with serious respiratory complications.
-
Some elderly and sick patients benefit from a minimally invasive treatment of an aortic aneurysm. However, open aortic artery operations continue to be a good (and in cases the only sensible) alternative.
-
Researchers identified thousands of specific peptides on the surface of cells for the first time. These so-called cryptic peptides mark tumor cells to a significant extent and may provide a new starting point for cancer immunotherapies.
-
Outcomes of the C-OPTIMISE trial showed that a reduced maintenance dose of certolizumab pegol may be used in patients with axial spondyloarthritis (axSpA) treated with the drug for a year and who achieved sustained disease remission, regardless of subpopulation.
-
A concept of the new ‘Composite of Relevant Endpoints for Sjogren’s Syndrome’ (CRESS) has been developed, which enables discriminating between abatacept and placebo response in patients with this condition.
-
Data from the first large, randomized, placebo-controlled trial OA TREAT, focusing on erosive hand osteoarthritis, showed that hydroxychloroquine was no more effective than placebo for changes in pain, function, and radiographic scores in the study period.
